에 대한 최신 뉴스 PyroGenesis (OTC:PYRGF) 주식

PyroGenesis Inc formerly, PyroGenesis Canada Inc is engaged in the design, development, manufacture, and commercialization of advanced plasma processes and systems. It provides technical & manufacturing expertise, cutting-edge contract research, and turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil & gas, and environmental industries. Its Product categories include Aluminum & Zinc Dross Recovery, Plasma Atomized Metal Powders, Waste Management, Innovation/Custom Process Development, and Plasma Torches. Its geographical segments are Brazil, Canada, United States, Mexico, Israel, Saudi Arabia, India, Africa, England, Germany, Netherlands, Poland, Spain and Vietnam. The Majority of revenue is generated from Canada.

Intel's Setbacks

Equities

Large Cap

News

Movers

Trading Ideas

INTC

PYRGF

RBRK

SMCI

SMMT

이들 10개의 대형주가 지난주에 가장 좋은 성과를 보였다. 당신의 포트폴리오에 있나요? 1. 루브릭(NYSE:RBRK)의 주식은 4분기 실적이 긍정적으로 나타난 후 23.17% 급등했으며, 여러 애널리스트들이 주가 전망을 수정했다.

앱러빈, 슈퍼 마이크로 컴퓨터, 인텔 등 지난주 급등한 대형주 10종목 (3월 10일-3월 14일)

PyroGenesis Inc

Telsey Advisory Group analyst Joseph Feldman maintains Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) with a Market Perform and lowers the price target from $115 to $85.

Price Target

Analyst Ratings

FIVE

Telsey Advisory Group Maintains Market Perform on Five Below, Lowers Price Target to $85

Sweden-based Dellner Couplers brings an 84-year legacy of innovation in train connection systems, which positioned the company as an industry leader in manufacturing and servicing of couplers for the transit rail industry.
The acquisition is anticipated to provide immediate shareholder value with an accretive growth profile, accretive Adjusted EBIT margins, accretive Adjusted EPS in the first year of ownership and accretive return on invested capital (ROIC) over time.&nbsp;

Wabtec Agrees To Acquire Sweden-Based Dellner Couplers For $960M Cash

Nikhil Lalwani, President and CEO of ANI stated, "This transaction reflects our commitment to strengthening our Retina portfolio and maximizing the long-term value of ILUVIEN and YUTIQ. By eliminating this royalty obligation, we have enhanced our financial flexibility and ability to accelerate growth as we pursue our purpose of ‘Serving Patients, Improving Lives.'"

Health Care

General

ANIP

ANI Pharmaceuticals Completed The Buyout Of Its 3.125% Perpetual Royalty Obligation To SWK Funding On Worldwide Net Revenues Of Iluvien And Yutiq For A One-time Payment Of $17.25M

Earnings

BEKE

KE Holdings Q4 Adj EPADS $0.16 Misses $0.26 Estimate, Sales $4.26B Beat $4.01B Estimate

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) from Neutral to Neutral.

Reiteration

AGEN

HC Wainwright & Co. Reiterates Neutral on Agenusto Neutral

Booz Allen Partners With Shield AI To Deliver AI-Enabled Software-Defined Autonomous Solutions For US Government

ETON

Eton Pharmaceuticals Q4 2024 GAAP EPS $(0.02) Vs. $(0.09) YoY, Sales $11.65M Beat $10.53M Estimate

Guidance

CTRN

Citi Trends Sees FY25 Comparable Store Sales Growth Of Low To Mid-Single Digits

Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $0.18 by 1050 percent. This is a 422.64 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $211.17 million which missed the analyst consensus estimate of $211.54 million by 0.17 percent. This is a 1.86 percent decrease over sales of $215.18 million the same period last year.

Earnings Misses

Citi Trends Q4 Adj $(1.71) Misses $0.18 Estimate, Sales $211.17M Miss $211.54M Estimate

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Sana Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) with a Buy and maintains $11 price target.

SANA

HC Wainwright & Co. Reiterates Buy on Sana Biotechnology, Maintains $11 Price Target

NIO Inc.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>)&nbsp;shares are trading <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">higher in the premarket </a>session on Tuesday.
NIO and Contemporary Amperex Technology Co., Ltd. (CATL) have <a target="_blank" href="https://www.nio.com/news/20250318001" rel="noreferrer noopener">joined </a>forces to enhance the development of the new energy vehicle sector.
On Monday, the companies announced a strategic partnership to establish a comprehensive battery swapping network for passenger vehicles, optimize industry standards, and provide efficient recharging solutions.
William Li, founder and CEO of NIO, and Dr. Robin Zeng, chairman and CEO of CATL, were both present at the signing ceremony, marking the beginning of this major strategic venture.
NIO has established a vast network of charging and battery swapping stations across China, surpassing 3,000 Power Swap Stations.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/03/44359600/hyperfine-nvidia-partner-to-make-brain-mris-more-affordable" rel="noreferrer noopener">Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable</a>
The company aims to expand this network considerably by 2025, reaching additional cities and county-level areas.
In March 2024, NIO and CATL inked a framework agreement to promote innovation in the R&amp;D of long-life batteries jointly.
&#8220;The strategic cooperation between NIO and CATL marks a pivotal moment, propelling battery swapping into a brand-new phase,&#8221; said Li.
CATL&#8217;s investment of up to RMB 2.5 billion (~$346 million) in NIO Power will strengthen this strategic partnership. CATL will assist NIO in enhancing its battery-swapping network. Additionally, they will collaborate to establish national standards for battery-swapping technology in China, which will improve compatibility among various brands.
&#8220;Leveraging our Choco-Swap and the parallel operations of both CATL&#8217;s and NIO&#8217;s networks, we are able to build a smart power network that caters to a wide range of needs across multiple levels and dimensions. This will enable every battery to deliver greater value throughout its lifecycle, and allow us to provide global users with safer, more efficient, and more sustainable electric mobility solutions,&#8221; said Zeng.
NIO will report its fourth quarter&nbsp;results on Friday, March 21, 2025, before the open of the U.S. markets.
Price Action: NIO shares traded higher by 5.77% at $5.32 in premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44358047/pepsico-bets-big-on-prebiotic-sodas-with-1-95-billion-poppi-acquisition-details" target="_blank" rel="noreferrer noopener">PepsiCo Bets Big On Prebiotic Sodas With $1.95 Billion Poppi Acquisition: Details</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Contracts

What's Going On With NIO Stock Today?

B of A Securities analyst Julien Dumoulin-Smith maintains American Electric Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) with a Buy and raises the price target from $108 to $114.

B of A Securities Maintains Buy on American Electric Power, Raises Price Target to $114

B of A Securities analyst Allen Lutz maintains Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) with a Underperform and raises the price target from $21 to $22.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

B of A Securities Maintains Underperform on Hims & Hers Health, Raises Price Target to $22

HC Wainwright &amp; Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) with a Buy and maintains $100 price target.

BLTE

HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $100 Price Target

BBAI

BigBear.ai Estimates Restatement To Change 2023 Income Before Taxes To $(71.3)M From Prior $(60.3)M, To Change 2024 Income Before Taxes To $(296.1)M From Prior $(257.1)M

VIAV

VIAVI Launches 800G Module Expanding Portfolio Of High-Speed Test Solutions

Carter's Launches Spring Break Collection Curated By Social Media Star Baby Kate

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOSS#NASDAQ">GOSS</a>) with a Buy and maintains $10 price target.

GOSS

HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

BigBear.ai Identifies Need To Restate Certain Prior Financial Statements - Filing

CMPS

Compass Pathways Publishes Results From COMP360 Psilocybin Study Indicating Longer-Term antidepressant Effects With 25mg Dose

Press Releases

PyroGenesis Provides Update on Impact of Potential U.S. Tariffs

PFAS Destruction Testing Confirms That PyroGenesis' Plasma Torches Reduce Energy Requirements By Up To 45%

PyroGenesis Provides Guidance for Q4 and Full-Year 2024

PyroGenesis Signs $725,000 Contract with Global Environmental Services Company

PyroGenesis Signs $2.4 Million Contract with Norsk Hydro ASA

PyroGenesis Announces First Material Produced from Fumed Silica Reactor

Technical Requirements for Titanium Coarse Metal Powder Have Been Met by PyroGenesis' NexGen™ Plasma Atomized Metal Powder for Global Aerospace OEM

PyroGenesis Improves Key Performance Parameters of its NexGenTM Plasma Atomized Metal Powder Production System

PyroGenesis Provides Response to Impact of U.S. Tariffs

PyroGenesis and GE Vernova Sign Memorandum of Understanding (MOU)

TSX:PYR

PyroGenesis

이들 10개의 대형주가 지난주에 가장 좋은 성과를 보였다. 당신의 포트폴리오에 있나요?
1. 루브릭(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>)의 주식은 4분기 실적이 긍정적으로 나타난 후 23.17% 급등했으며, 여러 애널리스트들이 <a href="https://www.benzinga.com//node/44334469" target="_blank" rel="noreferrer noopener">주가 전망을 수정</a>했다.
2. 앱러빈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>)의 주식은 기술 부문이 주 초의 약세에서 반등함에 따라 17.21% 상승했다.
3. 서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주식은 에버코어 ISI 그룹이 주식을 아웃퍼폼 등급으로 분석을 시작하고 <a href="https://www.benzinga.com/quote/smmt/analyst-ratings" target="_blank" rel="noreferrer noopener">30달러의 주가 전망을 발표</a>한 후 16.93% 급등했다.
4. 인텔(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)의 주식은 <a href="https://www.benzinga.com//node/44302205" target="_blank" rel="noreferrer noopener">회사가 새로운 CEO를 발표</a>한 후 16.52% 상승했다.
5. 벤처 글로벌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VG#NYSE">VG</a>)의 주식은 Form 4 신고서에 여러 내부자가 주식을 구매한 내용이 나타난 후 16.03% 상승했다.
6. GE 버노바(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>)의 주식은 회사가 파이로제네시스(OTC:<a class="ticker" href="https://www.benzinga.com/stock/PYRGF#OTC">PYRGF</a>)와 화석 연료를 전기 플라즈마로 대체하기 위한 양해각서(MOU)를 체결했다고 발표한 후 14.01% 상승했다.
7. 삼사라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>)의 주식은 11.96% 상승했다.
8. 안테로 리소스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>)의 주식은 아마도 달러 약세로 지지받은 유가 상승으로 11.68% 증가했다.
9. 슈퍼 마이크로 컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)의 주식은 새로운 인텔 제온 6세대 기반 서버를 발표한 후 10.28% 상승했다. 이 서버는 인공지능(AI) 성능을 향상시키고 메모리를 40% 더 늘려주며 CPU 코어를 144개 추가했다.
10. 코노코필립스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>)의 주식은 석유와 천연가스 가격의 강세로 9.18% 상승했다.
이미지 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

PyroGenesis

뉴스

에 대한 최신 뉴스 PyroGenesis (OTC:PYRGF) 주식

일요일, 3월 16, 2025

뉴스

파트너 / 기고자

벤징가 글로벌